Literature DB >> 25424206

Mycoplasma-associated Stevens-Johnson syndrome in children: retrospective review of patients managed with or without intravenous immunoglobulin, systemic corticosteroids, or a combination of therapies.

Jusleen Ahluwalia1, Joy Wan, Diana H Lee, James Treat, Albert C Yan.   

Abstract

Administration of intravenous immunoglobulin (IVIG) to patients with Stevens-Johnson syndrome (SJS) has been controversial. The objective of this study was to evaluate the effectiveness of IVIG, systemic corticosteroids, or both in treating Mycoplasma pneumoniae-associated SJS (mpSJS). Retrospective series of 10 pediatric mpSJS cases were stratified into four treatment groups: IVIG alone, IVIG and systemic corticosteroids together, systemic corticosteroids alone, and supportive care. The efficacy of therapy was evaluated on the basis of several proxies of disease severity, including hospital length of stay (LOSt ) and number of febrile days (Febt ) after initiation of therapy. Patients treated with IVIG alone had a longer LOSt and more Febt , despite different baseline characteristics, than patients treated with supportive therapy. Of patients who received IVIG, 50% were treated with corticosteroids concurrently and had similar characteristics of disease severity but showed a non-statistically significant trend toward shorter LOSt and fewer Febt than those who received IVIG alone. A patient treated with corticosteroids alone had the shortest LOSt in this series. Therefore treatment with IVIG alone was associated with a more severe disease course than supportive therapy, although causality cannot be inferred given possible confounding by indication. When systemic corticosteroids were used alone or in conjunction with IVIG, hospital LOSt and Febt trended lower than with the use of IVIG alone, although disease severity at baseline was similar between those treated with IVIG and corticosteroids concurrently and those treated with IVIG alone. It was thus concluded that treatment with systemic corticosteroids as monotherapy or in combination with IVIG may be preferable to IVIG alone. Further large-scale studies are warranted to evaluate this hypothesis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25424206     DOI: 10.1111/pde.12481

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  5 in total

1.  Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.

Authors:  Li-Shen Shan; Xin Liu; Xin-Yuan Kang; Fei Wang; Xiao-Hua Han; Yun-Xiao Shang
Journal:  World J Pediatr       Date:  2017-01-27       Impact factor: 2.764

2.  The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.

Authors:  Liang-Ping Ye; Cheng Zhang; Qi-Xing Zhu
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

3.  Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015.

Authors:  Waleed M Sweileh
Journal:  Orphanet J Rare Dis       Date:  2017-01-18       Impact factor: 4.123

Review 4.  Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.

Authors:  Hyeon-Jong Yang; Dae Jin Song; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2017-06-22

5.  Injection of immunoglobulin in the treatment process of children with severe pneumonia.

Authors:  Liping Chen; Xuehai Qi; Ruiying Li; Xudong Wang; Baohai Shi; Qingmei Meng
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.